WEED, INC.

Overview

Compare with another stock.

• TickerBUDZ on OTC¹
• IndustryServices-Commercial Physical & Biological Research¹
• HeadquartersTucson, Arizona¹
• Incorporated inNV²
• Business address4920 N. Post Trail, Tucson, Az 85750²
• Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

We were originally incorporated under the name Plae, Inc., in the State of Arizona on August 20, 1999. At the time we operated under the name Plae, Inc., no business was conducted. No books or records were maintained and no meetings were held. In essence, nothing was done after incorporation until Glenn E. Martin took possession of Plae, Inc. in January 2005. On February 18, 2005, the corporate name was changed to King Mines, Inc. and then subsequently changed to its current name, United Mines, Inc., on March 30, 2005. No shares were issued until the Company became United Mines, Inc. From 2005 until 2015, we were an exploration stage mineral exploration company that owned a number of unpatented BLM mining claims and Arizona State Land Department exploration leases.³ From its latest annual report

What it owns

What WEED, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Intangibles and goodwill

Properties, in its own words

New York Property

On November 22, 2021, we acquired certain improved property located in Westfield, New York from DiPaolo for a total purchase price of $477,000. The property is approximately 44 acres and has unlimited water extraction rights from the State of New York. We plan to use this property as our inroads to the New York hemp and infused beverage markets in the future.

Item 2 of the 10-K filed Apr 8, 2026.³

Leadership

Who has led WEED, INC., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerGlenn E. Martin Dec 22, 2011 to Aug 14, 2018¹⁴
• Chief executive officerRobert A. Leitzman Dec 23, 2009 to Dec 23, 2009¹⁵
• ChairGlenn E. Martin Oct 15, 2009 to Dec 22, 2011¹⁶
• PresidentGlenn E. Martin Oct 15, 2009 to Dec 22, 2011¹⁶
• Chief financial officerGlenn E. Martin Dec 22, 2011 to Aug 14, 2018¹⁴
• Chief financial officerRobert A. Leitzman Oct 15, 2009 to Oct 15, 2009¹⁷

Former names

• UNITED MINES INCMar 14, 2007 to Sep 16, 2014²

Timeline

1. Aug 4, 20228-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure²⁷
2. Dec 10, 20218-K Entered a material agreement; Regulation FD disclosure²⁸
3. Dec 22, 2011New chief executive Glenn E. Martin becomes CEO¹⁴
4. Dec 23, 2009New chief executive Robert A. Leitzman becomes CEO¹⁵

Filings

55 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 2 major events, 23 insider forms, 9 other. The latest 20:

1. Aug 21, 20264 PRIMARY DOCUMENT EDGAR
2. Aug 14, 202610-Q EDGAR
3. Jul 1, 2026144 EDGAR
4. Jun 12, 20264 PRIMARY DOCUMENT EDGAR
5. May 15, 202610-Q EDGAR
6. Apr 8, 202610-K EDGAR
7. Mar 31, 2026NT 10-K FORM NT 10-K FILING EDGAR
8. Mar 19, 2026144 EDGAR
9. Feb 24, 20264 PRIMARY DOCUMENT EDGAR
10. Dec 29, 202510-Q/A EDGAR
11. Dec 23, 202510-Q EDGAR
12. Dec 4, 2025144 EDGAR
13. Nov 14, 2025NT 10-Q FORM NT 10-Q FILING EDGAR
14. Aug 15, 2025144 EDGAR
15. Aug 14, 202510-Q EDGAR
16. May 15, 202510-Q EDGAR
17. Mar 31, 202510-K WEED, INC. FORM 10-K EDGAR
18. Nov 14, 202410-Q EDGAR
19. Aug 14, 202410-Q EDGAR
20. May 15, 202410-Q EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

48 open-market trades by officers, directors and large owners since October 2021: 0 buys and 48 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

SEC filer profile

How WEED, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARWEED, INC.¹
• CIK0001393772
• Employer ID (EIN)83-0452269³
• Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company³
• Incorporated inNevada³
• Fiscal year endsDecember 31¹
• Industry code (SIC)8731 Services-Commercial Physical & Biological Research¹
• SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance¹
• Business address4920 N. Post Trail, Tucson, AZ 85750¹
• Phone520-818-8582¹
• Shares outstanding148,312,685 as of Aug 14, 2026¹³
• Public float$1.5M as of Jun 30, 2025³
• AuditorM&K CPAS, PLLC, Woodlands, Texas PCAOB ID 2738; no auditor attestation of internal control over financial reporting³
• On EDGAR sinceMar 14, 2007¹
• Filings274 in all: 4 (112), 10-Q (34), 8-K (21), 10-K (11), 3 (11), NT 10-Q (11), UPLOAD (11), 424B3 (10)¹
  All 30 form types

  S-1/A (10), 144 (7), NT 10-K (4), 1-A/A (3), CORRESP (3), EFFECT (3), 10-K/A (2), 10-Q/A (2), 253G2 (2), 8-A12G (2), DEF 14A (2), DEF 14C (2), S-1 (2), 1-A (1), 15-12G (1), 4/A (1), D (1), D/A (1), DEFA14A (1), POS AM (1), QUALIF (1), REGDEX (1)

• Latest filingsAnnual report (10-K) Apr 8, 2026
  Quarterly report (10-Q) Aug 14, 2026
  Proxy statement (DEF 14A) Jul 20, 2012
  Latest 8-K (8-K) Aug 4, 2022

Risk factors and legal proceedings

The risks WEED, INC. names in Item 1A of its 10-K filed Apr 8, 2026: 19 risks under these headings, as written.³

• Substantial doubt about our ability to continue as a going concern
• We have a limited operating history and historical financial information upon which you may evaluate our performance.
• We may not be able to meet our future capital needs.
• If we cannot obtain additional funding, our research and development efforts may be reduced or discontinued and we may not be able to continue operations.
• One of our current projects is our 5-year cannabis genomic study being conducted by Sangre. In the event that we are unable to complete that study for any reason, such as inability to complete our human clinical trials, or if those trials are not successful, then it could significantly impact our business.
• Our research plan, which is focused on the development and application of cannabis-derived compounds for the treatment of human disease and includes our 5-year cannabis genomic study being conducted by Sangre, is dependent upon our ability to complete the necessary research and clinical human trials.
• There can be no guarantee that we will successfully launch WEEDCoin or BUDZCoin.
• Current economic conditions and capital markets are in a period of disruption and instability which could adversely affect our ability to access the capital markets, and thus adversely affect our business and liquidity.
• Our proposed business is dependent on laws pertaining to the cannabis industry.
• The cannabis industry faces strong opposition.
• Cannabis remains illegal under Federal law.
• Laws and regulations affecting the medical cannabis industry are constantly changing, which could detrimentally affect our proposed operations.

Legal proceedings

In the ordinary course of business, we are from time to time involved in various pending or threatened legal actions. The litigation process is inherently uncertain, and it is possible that the resolution of such matters might have a material adverse effect upon our financial condition and/or results of operations. However, in the opinion of our management, other than as set forth herein, matters currently pending or threatened against us are not expected to have a material adverse effect on our financial position or results of operations.

The opening of Item 3, Legal Proceedings.³